✦ LIBER ✦

AP24163 Inhibits the Gatekeeper Mutant of BCR-ABL and Suppresses In vitro Resistance

✍ Scribed by Mohammad Azam; John T. Powers; William Einhorn; Wei-Sheng Huang; William C. Shakespeare; Xiaotian Zhu; David Dalgarno; Tim Clackson; Tomi K. Sawyer; George Q. Daley

Book ID: 111368785
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 306 KB
Volume: 75
Category: Article
ISSN: 1747-0277
DOI: 10.1111/j.1747-0285.2009.00911.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro Activity of Bcr-Abl Inhibitors

In vitro Activity of Bcr-Abl Inhibitors AMN107 and BMS-354825 against Clinically Relevant Imatinib-Resistant Abl Kinase Domain Mutants

✍ O'Hare, T. 📂 Article 📅 2005 🏛 American Association for Cancer Research 🌐 English ⚖ 846 KB

The gatekeeper mutation T315I confers re

The gatekeeper mutation T315I confers resistance against small molecules by increasing or restoring the ABL-kinase activity accompanied by aberrant transphosphorylation of endogenous BCR, even in loss-of-function mutants of BCR/ABL

✍ Mian, A A; Schüll, M; Zhao, Z; Oancea, C; Hundertmark, A; Beissert, T; Ottmann, 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 465 KB

The presence of a BCR-ABL mutant allele

The presence of a BCR-ABL mutant allele in CML does not always explain clinical resistance to imatinib

✍ Khorashad, J S; Anand, M; Marin, D; Saunders, S; Al-Jabary, T; Iqbal, A; Margeri 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 129 KB

Activity of a novel Aurora kinase inhibi

Activity of a novel Aurora kinase inhibitor against the T315I mutant form of BCR-ABL: In vitro and in vivo studies

✍ Daigo Akahane; Tetsuzo Tauchi; Seiichi Okabe; Kousuke Nunoda; Kazuma Ohyashiki 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 451 KB

Increasing the BCR-ABL expression levels

Increasing the BCR-ABL expression levels and/or the occurrence of ABL point mutations does not always predict resistance to Imatinib Mesylate in BCR-ABL positive acute lymphoblastic leukemia

✍ S. Grammatico; L. Elia; A.L. Peluso; L. Pedace; M. Matarazzo; A. Vitale; A. Rago 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 275 KB

Bcr-Abl Kinase Domain Mutations and the

Bcr-Abl Kinase Domain Mutations and the Unsettled Problem of Bcr-AblT315I: Looking into the Future of Controlling Drug Resistance in Chronic Myeloid Leukemia

✍ O'Hare, Thomas; Eide, Christopher A.; Deininger, Michael W. 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 362 KB